Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 45
Filtrar
3.
Chemotherapy ; 33(4): 234-9, 1987.
Artigo em Inglês | MEDLINE | ID: mdl-3608622

RESUMO

Any significant change in the pharmacokinetics of an anticancer drug would have a bearing on its therapeutic efficacy and toxicity. Nutritional deficiencies have been shown to affect the pharmacokinetics of a drug. Since malnutrition and undernutrition are widely prevalent in India, the effect of initial nutritional status on the overall kinetics of methotrexate (MTX) administered to cancer patients appeared to be of practical importance. A study of 6 Indian children with malignancies was made to examine the pharmacokinetics of low dose MTX and its relationship to the nutritional status. The results indicate that the relative weight correlates well with the anthropometric parameters, nutritional parameters and dietary intake and may be used as a marker of nutritional status.


Assuntos
Metotrexato/metabolismo , Estado Nutricional , Adolescente , Antropometria , Proteínas Sanguíneas/análise , Criança , Pré-Escolar , Feminino , Humanos , Índia , Lactente , Cinética , Masculino , Metotrexato/uso terapêutico , Neoplasias/tratamento farmacológico
11.
Cancer ; 55(3): 605-7, 1985 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-3838083

RESUMO

The activity of a heat labile variant of Regan type alkaline phosphatase (HLRI) was studied in the serum of 38 histologically proved patients with Hodgkin's disease. The activity was also studied in 40 normal healthy adults matched for age and sex as control. HLRI was significantly elevated in patients with Hodgkin's disease in comparison with normal controls (1.12 +/- 0.12 units/ml vs 0.09 +/- 0.01 units/ml; P less than 0.001). The mean values of the isoenzyme tended to increase progressively with increasing stages of disease, reflecting a significant linear trend (P less than 0.001). The serial measurement of this variant may serve as a useful parameter in assessing disease activity and response to chemotherapy.


Assuntos
Doença de Hodgkin/enzimologia , Isoenzimas/sangue , Placenta/enzimologia , Adulto , Fosfatase Alcalina , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Proteínas Ligadas por GPI , Doença de Hodgkin/tratamento farmacológico , Doença de Hodgkin/patologia , Temperatura Alta , Humanos , Isoenzimas/genética , Mecloretamina/administração & dosagem , Estadiamento de Neoplasias , Prednisona/administração & dosagem , Procarbazina/administração & dosagem , Vincristina/administração & dosagem
14.
Cancer Treat Rep ; 68(5): 727-32, 1984 May.
Artigo em Inglês | MEDLINE | ID: mdl-6722831

RESUMO

Since anticancer drugs have a low therapeutic index, any significant change in the pharmacokinetics of a drug would have a bearing on therapeutic efficacy and drug toxicity. Nutritional deficiencies have been shown to affect the four processes of pharmacokinetics, ie, absorption, distribution, biotransformation, and excretion. Malnutrition and undernutrition are widely prevalent in India and thus it was thought to be of practical importance to study the effect of initial nutritional status on the overall kinetics of methotrexate, a widely used anticancer drug. The results of the study reveal that relative weight correlates well with the anthropometric parameters, nutritional parameters, and dietary intake and may be used as a marker of nutritional status. When grouped on the basis of relative weights, the undernourished patients revealed a significant (P less than 0.01) prolongation of biological half-life and a significant (P less than 0.001) reduction in clearance. Based on these results, relative weight has been proposed as a basis for drug dosage determinations in place of the existing practice of administering antineoplastic drugs on the basis of body surface area or body weight alone.


Assuntos
Neoplasias de Cabeça e Pescoço/metabolismo , Metotrexato/metabolismo , Necessidades Nutricionais , Adulto , Antropometria , Biotransformação , Peso Corporal , Dieta , Meia-Vida , Neoplasias de Cabeça e Pescoço/tratamento farmacológico , Humanos , Índia , Cinética , Metotrexato/uso terapêutico , Modelos Biológicos , População Branca
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA